4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-057052
EVP, Chief Medical Officer sold 589 shares at $19.46 ($11,462)
- EVP, Chief Medical Officer acquired 2,413 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shah Jatin · EVP, Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-07-11 | Exercise or conversion : show line 1 in the form | +2,413 | 43,172 | D | ||
| 2020-07-15 | Sale : show line 2 in the form | −589 | $19.46 | $11,462 | 43,229 | D |
| Open-market sales · 589 sh · avg $19.46 · $11,462 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2020-07-11 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −2,413 | 2,413 | 7,237 | D |
Loading xslF345X03/doc4.xml…